Repare Therapeutics Inc (RPTX)

Repare Therapeutics Inc Azioni (RPTX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	301.66% 52.40	13.05	2.159	30.25	5.678
Operating Expenses	5.30% 41.59	43.91	40.58	42.51	40.36
Benefits Costs and Expenses	5.56% 38.61	40.89	37.34	39.09	37.00
Costs And Expenses	5.30% 41.59	43.91	40.58	42.51	40.36
Provision For Loan, Lease, And Other Losses	1.08% 0.563	0.557	0.551	0.545	0.541
Operating Income/Loss	135.04% 10.82	-30.87	-38.42	-12.26	-34.68
Nonoperating Income/Loss	1.72% 2.975	3.027	3.24	3.422	3.356
Income/Loss From Continuing Operations Before Tax	149.54% 13.79	-27.84	-35.18	-8.836	-31.32
Income Tax Expense/Benefit	231.05% 0.629	0.19	-16.30	3.11	3.616
Income/Loss From Continuing Operations After Tax	146.96% 13.16	-28.03	-18.88	-11.95	-34.94
Net Income/Loss	146.96% 13.16	-28.03	-18.88	-11.95	-34.94
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	273.51K% 42.23	0.0154	42.10	42.09	42.04
Diluted Average Shares	285.10K% 44.02	0.0154	42.10	42.09	42.04
Basic Earnings Per Share	146.27% 0.31	-0.67	-0.45	-0.28	-0.83
Diluted Earnings Per Share	144.78% 0.30	-0.67	-0.45	-0.28	-0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-